| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/30/2008 | CN101171261A Immunoglobulin fraction and process therefor |
| 04/30/2008 | CN101171035A Methods and compositions for modulating TWEAK and FN14 activity |
| 04/30/2008 | CN101171019A Immune function modulating agents |
| 04/30/2008 | CN101171013A Use of pyrimidylamimobenzamide derivatives for the treatment of systematic mastocytosis |
| 04/30/2008 | CN101171003A Cytokine modulators using cyclic glycerides of essential poyunsaturated fatty acids |
| 04/30/2008 | CN101168067A Method for decreasing immune cell surface antigenic sites immunogenicity and use |
| 04/30/2008 | CN101168050A Immunity regulating medicinal composition |
| 04/30/2008 | CN101168037A Traditional Chinese medicine for treating urticaria and invigorating spleen and dispelling wind-evil |
| 04/30/2008 | CN101167995A Traditional Chinese medicinal composition for treating infantile eczema |
| 04/30/2008 | CN101167992A Cool health-care beer capable of balanced fat-reducing, overall preventing cough and diabetes and beautifying |
| 04/30/2008 | CN101167923A Preparation of six ingredients with rehmannia and its application in cigarette |
| 04/30/2008 | CN101167919A Medicine composition capable of promoting the growth of bone tissue and preparation technology and application thereof |
| 04/30/2008 | CN101167918A Traditional Chinese medicinal preparation for increasing immunity of pig or poultry |
| 04/30/2008 | CN101167896A Method for making capsule for beautifying |
| 04/30/2008 | CN101167886A 'Yishoudixian' orally-administered traditional Chinese medicine preparation and preparation method thereof |
| 04/30/2008 | CN101167882A Capsule for anti-oxidation |
| 04/30/2008 | CN101167868A Traditional Chinese medicine for treating urticaria and invigorating blood and dispelling wind-evil |
| 04/30/2008 | CN101167867A Traditional Chinese medicine for treating urticaria and cooling blood and reducing damp |
| 04/30/2008 | CN101167851A External-applied chrisma for treating infantile eczematization |
| 04/30/2008 | CN101167833A Method for preparing raspberry superfine powder by gas phase method and solid phase method superfine crushing technology |
| 04/30/2008 | CN101167793A Walnut oil fat emulsion and manufacturing method thereof |
| 04/30/2008 | CN101167788A Quality control method of 'zhenqi fuzheng' containing glossy privet fruit and radix astragali for strengthening the body resistance traditional Chinese medicine for aeipathia deficiency damage and qi |
| 04/30/2008 | CN101167772A Health-care product with strengthening physique immunity for dog and cat |
| 04/30/2008 | CN101167768A A pharmaceutical formulation for treating acquired immune deficiency syndrome (AIDS) and its preparation method |
| 04/30/2008 | CN101167762A Method for preparing health-care capsule with mutation-resisting and immunoregulating function |
| 04/30/2008 | CN101167730A Compound betamethasone suspension injection |
| 04/30/2008 | CN101167505A Selenium rich rabdosia rubescens tea |
| 04/30/2008 | CN100385005C Methods for the production of multimeric proteins, and related compositions |
| 04/30/2008 | CN100385002C Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins |
| 04/30/2008 | CN100384880C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384879C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 04/30/2008 | CN100384844C Xanthine phosphodiesterase V inhibitor polymorphs |
| 04/30/2008 | CN100384838C Novel benzylpiperidine compound |
| 04/30/2008 | CN100384474C Skin immune function controlling agents |
| 04/30/2008 | CN100384472C Antigen-specific lgE antibody production inhibitors |
| 04/30/2008 | CN100384433C Remedies |
| 04/30/2008 | CN100384423C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/30/2008 | CN100384420C Use of substituted pyrazoles in preparing medicine compositions for treating allergies |
| 04/30/2008 | CN100384347C Food mother material and its making method |
| 04/30/2008 | CA2564924A1 Design of interferon-inducible protein-10 (ip-10 or cxcl10) chemokine analogs for the treatment of human diseases |
| 04/29/2008 | US7365191 immunology; antitumor agents; viricides; anticancer agents; antiinflammatory agents; oligosaccharde containing glucose, galactose, mannose |
| 04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365155 Immunoregulator |
| 04/29/2008 | US7365089 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/29/2008 | US7365067 Neurokinin receptors antagonists; asthma, bronchitis and chronic obstructive lung disease; allergic diseases such as rhinitis, urinary incontinence; 1-(2-{(2R)-2-(3,4dichlorophenyl)-4-[3,5-bis(trifluoromethyl)benzoyl]morpholin-2-yl}ethyl)spiro((2S)-2-{[(morpholin-1-yl)acetyl]oxy})indane-1,4'-piperidine |
| 04/29/2008 | US7364919 Immobilization carbohydrates; calibration; diagnosis; antiinflammatory agents, bactericides |
| 04/29/2008 | US7364864 ANGE gene in atopy |
| 04/29/2008 | US7364736 Immmunoglobulin which prevents binding of osteoprotegerin ligand (OPGL) to osteoclast differentiation and activation receptor (ODAR) for treatment and prevention of bone, inflammatory, arthritic and autoimmune disorders |
| 04/29/2008 | US7364733 antibodies that bind to Activated CD4+ T-cells (ACT-4) receptors; diagnostic or therapeutic use for immune disorders; selective suppression of immune response; allograft rejection, graft versus host disease, autoimmune diseases, allergies |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/29/2008 | CA2268957C Immune response modifier compounds for treatment of th2 mediated and related diseases |
| 04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
| 04/27/2008 | CA2571805A1 Tissue targeted antigenic activation of the immune response to cancers |
| 04/24/2008 | WO2008049123A2 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 04/24/2008 | WO2008049011A2 Alpha-msh therapies for treatment of autoimmune disease |
| 04/24/2008 | WO2008048611A1 Process for the synthesis of individual isomers of mono-peg cci-779 |
| 04/24/2008 | WO2008047880A1 Therapeutic agent for rheumatoid arthritis |
| 04/24/2008 | WO2008047831A1 Jak inhibitor |
| 04/24/2008 | WO2008047779A1 Therapeutic or prophylactic agent for atopic dermatitis |
| 04/24/2008 | WO2008046202A1 USE OF PYπDOXAL-5'-PHOSPHATE FOR IMPROVING THE IMMUNE RESPONSE AND TREATMENT AND PREVENTION OF POST-OPERATIVE INFECTIONS |
| 04/24/2008 | WO2008046162A1 Inhibition of degradation of extracellular matrix |
| 04/24/2008 | WO2008020206A3 Fused thiophene derivatives as mek inhibitors |
| 04/24/2008 | WO2008015374A3 Protein free formula |
| 04/24/2008 | WO2008009711A3 Use of soluble cd160 to suppress immunity |
| 04/24/2008 | WO2008001166A3 Process for synthesis of glycomimicking cationic amphiphiles |
| 04/24/2008 | US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug |
| 04/24/2008 | US20080097109 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096972 Compound formulations of 2-amino-1, 3-propanediol compounds |
| 04/24/2008 | US20080096953 N-(2-{2-[(2-Hydroxy-3-isobutyl-3-methyl-4-oxo-cyclobut-1-enyl)-phenyl-methyl]-6-methyl-1H-indol-3-yl}-1,1-dimethyl-ethyl)-acetamide, for example; useful as chymase inhibitors; treatment of allergy, asthma, peripheral arterial occlusive disease, irritable bowel disease |
| 04/24/2008 | US20080096949 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 04/24/2008 | US20080096943 Urea derivatives, for example, 1-(3,5-dimethyl-isoxazole-4-yl)-3-[4-[(4-fluorobenzyl)methylamino]-butyl]-urea; use in treating inflammatory or allergic condition such as an inflammatory or obstructive airways disease |
| 04/24/2008 | US20080096901 Aminotriazole compounds useful as inhibitors of protein kinases |
| 04/24/2008 | US20080096897 water soluble; lower toxicity by photosensitization; anticancer; antitumor; antiinflammatory; arthritis; osteoporosis; ocular abnormal angiogenesis; multiple sclerosis, asthma, atherosclerosis |
| 04/24/2008 | US20080096887 Benzene, Pyridine, and Pyridazine Derivatives |
| 04/24/2008 | US20080096861 Chemical Compounds |
| 04/24/2008 | US20080096845 Sphingomyelin therapy of autoimmune disease |
| 04/24/2008 | US20080096841 Using analogs of Lipid A such as Eritoran to treat or prevent mucositis, allograft/graft rejection, arteriosclerosis, atherosclerosis, hepatitis, asthma, and inflammatory bowel disease |
| 04/24/2008 | US20080096833 Diagnostic drugs and kits; coded for human proto-oncogene Pim-3, an antibody specific thereto; short interence RNA; genetic engineering |
| 04/24/2008 | US20080096830 9a-aza-9a-Homoerythromycin derivatives with a dibenzo[e,h]azulene subunit; asthma, adult respiratory distress syndrome; gastrointestinal, respiratory system, autoimmune, genetic, skin, rheumatic, or smooth muscular disorders; inhibitors of tumor necrosis factor, interleukins, leukotrienes, lipoxygenase |
| 04/24/2008 | US20080096820 Prodomain modulators of ADAM 10 |
| 04/24/2008 | US20080096266 Method for Stabilizing the Antiallergic Activity of Lactic Acid Bacteria Against High-Temperature Treatment, Stabilized Compositons, and Food and Drink |
| 04/24/2008 | US20080096263 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus |
| 04/24/2008 | US20080095854 Ballast administering to mammals skins; high density core overcoated with amorphous reservoir containing dna; drug delivery; containing free radical scavenger |
| 04/24/2008 | US20080095810 Nanoparticle systems for release of biologically active molecules formed by chitosan polymer or derivatives, chemically modified with polyethylene glycol and crosslinked with a crosslinking agent; especially useful for pharmaceutical compositions, vaccines and cosmetic formulations; controlled release |
| 04/24/2008 | US20080095802 Targeted delivery of cytotoxic drugs A) to activated lymphocytes in patients iwth transplanted organs, B) as radiosensitizers to cancer cells in paients undergoing radiation therapy, and C) in vitaminpbinding proteins as drug carriers in the diagnosis and treatment of cancer |
| 04/24/2008 | US20080095788 Vaccines |
| 04/24/2008 | US20080095774 Agents and Methods for Specifically Blocking CD28-Mediated Signaling |
| 04/24/2008 | US20080095771 Treatment Method |
| 04/24/2008 | US20080095769 Monoclonal antibody secific to lymphocyte peripheral membrane protein for treating and preventing transplant rejection, blood, skin, autoimmune, allergic and diabetic disorders |
| 04/24/2008 | US20080095766 Methods for the Treatment of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies with Reduced Toxicity |
| 04/24/2008 | US20080095765 IL-5R-specific antibody composition |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095745 Transgenic butyrivibrio fibrisolvens for use in treatment and prevention of infections, allergic and inflammatory bowel disease |
| 04/24/2008 | US20080095740 4-piperazine-4-piperidine-1-ketone derivatives; graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 04/24/2008 | US20080095738 Vlp-Antigen Conjugates and Their Uses as Vaccines |
| 04/24/2008 | US20080095710 Enzyme treatment of foodstuffs for celiac sprue |
| 04/24/2008 | CA2673125A1 Compositions and methods for inhibition of the jak pathway |